Related Experiment Video

Updated: May 26, 2026

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis
07:16

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis

Published on: September 20, 2024

Activity of pyocin S2 against Pseudomonas aeruginosa biofilms

Karen Smith1, Laura Martin, Angela Rinaldi

  • 1Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.

Antimicrobial Agents and Chemotherapy
|December 21, 2011
PubMed

Insights

Pyocin S2 effectively targets Pseudomonas aeruginosa biofilms, a common infection in cystic fibrosis patients. This research demonstrates pyocin S2

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Biotechnology

Background:

  • Chronic Pseudomonas aeruginosa lung infections significantly impact cystic fibrosis (CF) patient mortality.
  • P. aeruginosa biofilms are a key factor in persistent infections and lung function decline in CF.
  • Current therapeutic options for P. aeruginosa infections in CF have limitations.

Purpose of the Study:

  • To evaluate the efficacy of pyocin S2 against P. aeruginosa biofilms.
  • To assess the in vivo therapeutic potential of pyocin S2 in a relevant infection model.

Main Methods:

  • Assessing pyocin S2 activity against P. aeruginosa biofilms in vitro.
  • Utilizing an invertebrate model to study P. aeruginosa infection dynamics.
  • Evaluating pyocin S2 efficacy in the invertebrate infection model.

Main Results:

  • Pyocin S2 demonstrated potent activity against P. aeruginosa biofilms.
  • Pyocin S2 showed significant therapeutic efficacy in an in vivo model of P. aeruginosa infection.
  • Pyocin S2 represents a promising new agent for combating P. aeruginosa infections.

Conclusions:

  • Pyocin S2 is a potent anti-biofilm agent against P. aeruginosa.
  • Pyocin S2 shows promise as an in vivo therapeutic for P. aeruginosa infections, particularly in cystic fibrosis.
  • Further investigation into pyocin S2 as a cystic fibrosis treatment is warranted.

More Related Videos

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries09:39

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries

Published on: December 27, 2016

Targeting Biofilm Associated Staphylococcus aureus Using Resazurin Based Drug-susceptibility Assay10:00

Targeting Biofilm Associated Staphylococcus aureus Using Resazurin Based Drug-susceptibility Assay

Published on: May 5, 2016

Related Concept Videos

Biofilms01:29

Biofilms

Biofilms are complex communities of microorganisms encased in a self-produced extracellular polysaccharide matrix attached to surfaces. These microbial consortia can include single or multiple species, providing enhanced survival benefits by forming organized, multilayered structures.The formation of biofilms occurs through four key stages: attachment, colonization, development, and dispersal.During attachment, free-swimming planktonic cells adhere to a surface, often facilitated by...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...